CML-IQ mailers are sent by:
Lind Publishing Inc.
Email address: info@CML-IQ.com
CML-IQ is published by Lind Publishing Inc. CML-IQ is a free, independent, un-biased source of news, offering useful and practical advice about Chronic Myelogenous Leukemia (CML) to enable people to gain a greater understanding of the disease, the treatments and research avenues being explored.
Subscriptions to CML-IQ News are free upon sign-up. All sign-up information, including e-mail addresses, will be kept strictly confidential and will not be shared with any third parties.
All content published on CML-IQ is written by our editorial committee and other qualified authors selected by us.